Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients.
Bins S, Huitema ADR, Laven P, Bouazzaoui SE, Yu H, van Erp N, van Herpen C, Hamberg P, Gelderblom H, Steeghs N, Sleijfer S, van Schaik RHN, Mathijssen RHJ, Koolen SLW.
Bins S, et al. Among authors: koolen slw.
Clin Pharmacokinet. 2019 May;58(5):651-658. doi: 10.1007/s40262-018-0719-5.
Clin Pharmacokinet. 2019.
PMID: 30367352
Free PMC article.
Clinical Trial.